February 25, 2022
Sobi’s HLH Drug Recommended for Approval in China
Sobi has announce that the Center for Drug Evaluation (CDE) has recommended approval of Gamifant to the National Medical Products…
Pharmaceuticals, Biotechnology and Life Sciences
Author: Dino Mustafić
February 25, 2022
Valneva Receives Initial CHMP Assessment of its Inactivated, Adjuvanted COVID-19 Vaccine Candidate VLA2001
Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, has announced that the Committee for Medicinal Products for…
February 25, 2022
Idorsia’s QUVIVIQ (daridorexant) Recommended for Approval in Europe as a New Treatment for Adults with Insomnia Disorder
Idorsia Ltd has announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European…
February 25, 2022
Max Perutz Labs Welcomes Stephanie Ellis as a New Group Leader
Max Perutz Labs has welcomed Stephanie Ellis as a new group leader. Stephanie Ellis has joined Max Perutz Labs from…
February 22, 2022
dievini quits selling CureVac’s common shares to the public
dievini Hopp BioTech holding GmbH & Co. KG (dievini), DH-LT-Investments GmbH and Dietmar Hopp, as well as the managing directors…
February 22, 2022
TargED raises Series A financing of EUR 39 million to accelerate development of its lead compound
TargED Biopharmaceuticals (“TargED”), a private biotechnology company focused on developing improved treatments for thrombotic diseases, has announced it has raised…
February 22, 2022
Myricx Pharma announces senior team expansion with appointment of CMO, and Heads of Biology and Bioinformatics
Myricx Pharma (‘Myricx’), a drug discovery company focused on developing small molecule inhibitors that selectively target the human N-myristoyltransferases (NMT)…
February 21, 2022
Thermo Fisher Scientific launches new portfolio of chromatography and mass spectrometry consumables
Thermo Fisher Scientific has launched a new collection of caps, vials, inserts, kits, well plates and mats improves analytical performance…
February 21, 2022
Potentially life-saving treatment is safe to use for babies with neonatal sepsis, study reveals
GARDP (Global Antibiotic R&D Partnership) has announced that results from a clinical trial completed in Kenya have determined that a…
February 21, 2022
Molecule partners to develop Web3-based ecosystem addressing inefficiencies in biopharma R&D
Molecule, a biotech IP Web3 marketplace, has announced a tripartite partnership with Apollo Health Ventures, a longevity-focused venture capital fund,…